COVID-19 update: July 8, 2022

CDC releases interim recommendations for use of Moderna and Pfizer-BioNTech vaccines for children from 6 months of age

CDC Advisory Committee on Immunization Practices has issued interim recommendations for the use of COVID-19 vaccines in children from 6 months of age. Read the release.

FDA recommends inclusion of Omicron BA.4/5 component for COVID-19 vaccine boosters

FDA advisory committee voted in favor of including a SARS-CoV-2 omicron component in COVID-19 vaccine boosters in the U.S. beginning in fall 2022.

The latest data on organ donation and transplant in the U.S.

Find high-level data on transplants, deceased donors recovered, patients added to the waitlist and patients temporarily moved to inactive waitlist status.

---

Reminders

CDC releases infographic showing COVID-19 vaccination schedule recommendations for patients

• CDC has released a new infographic showing vaccine schedules for most people and for those who are immunocompromised. See the infographic.

FDA announcements

• FDA expands Pfizer-BioNTech vaccine booster eligibility to children 5 through 11 years.
• FDA authorizes first nonprescription COVID-19 test that also detects flu and RSV. Read the release.
• FDA limits use of Janssen COVID-19 vaccine to certain individuals 18 years of age or older. Read the key points of this update.

Help your patients locate Evusheld therapy

• The U.S. Department of Health and Human Services maintains a national map displaying public locations that have received shipments of COVID-19 therapeutics such as Evusheld, Molnupiravir and Bebtelovimab. These therapies require a prescription, and the locator is intended for provider use.

---

Questions

• For COVID-19 related policy and operational questions, email [email protected]
• For information and updates about the status of in-person vs. virtual OPTN committee meetings, check the OPTN calendar of events.